Paper funded by the Myrovlytis Trust published

Wong and Harbottle (2013) successfully use a gene therapy approach to reinstate FLCN function in FLCN-null UOK-257 cells.

This work was funded by the Myrovlytis Trust, through a grant awarded to Professor Harbottle at Imperial College London, UK.